Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MITT
3676
TPG Mortgage Investment Trust
MITT
$226M
| $217K | ﹤0.01% |
40,901
-420,622
| -91% | -$2.17M |
|
3677
Great Southern Bancorp
GSBC
$890M
| $216K | ﹤0.01% |
3,639
+2,355
| +183% | +$143K |
|
3678
UFP Technologies
UFPT
$2.05B
| $216K | ﹤0.01% |
1,835
+1,530
| +502% | +$163K |
|
3679
iRadimed
IRMD
$1.16B
| $216K | ﹤0.01% |
7,646
+2,587
| +51% | +$74K |
|
3680
RCI Hospitality Holdings
RICK
$194M
| $215K | ﹤0.01% |
2,312
+1,875
| +429% | +$156K |
|
3681
Nature's Sunshine
NATR
$365M
| $215K | ﹤0.01% |
25,786
+3,033
| +13% | +$25.7K |
|
3682
Concrete Pumping Holdings
BBCP
$496M
| $214K | ﹤0.01% |
36,608
+30,626
| +512% | +$203K |
|
3683
CALL
Tidewater
TDW
$3.59B
| $214K | ﹤0.01% |
5,800
| – | – |
|
3684
Select Water Solutions
WTTR
$2.32B
| $213K | ﹤0.01% |
23,094
+16,154
| +233% | +$136K |
|
3685
Sibanye-Stillwater
SBSW
$6.25B
| $213K | ﹤0.01% |
+20,000
| New | +$203K |
|
|
PRLH
3686
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
| $213K | ﹤0.01% |
20,800
| – | – |
|
3687
SI-BONE Inc
SIBN
$817M
| $212K | ﹤0.01% |
15,605
+13,842
| +785% | +$202K |
|
3688
Richardson Electronics
RELL
$276M
| $212K | ﹤0.01% |
9,939
+6,237
| +168% | +$141K |
|
3689
Equinor
EQNR
$94.6B
| $211K | ﹤0.01% |
5,904
-13,493
| -70% | -$484K |
|
3690
BayCom
BCML
$340M
| $211K | ﹤0.01% |
11,139
+2,640
| +31% | +$49.6K |
|
|
LIAN
3691
DELISTED
LianBio American Depositary Shares
LIAN
| $211K | ﹤0.01% |
128,728
-139,672
| -52% | -$218K |
|
3692
Veru
VERU
$35.6M
| $210K | ﹤0.01% |
3,980
+3,704
| +1,342% | +$305K |
|
3693
Treace Medical Concepts
TMCI
$299M
| $210K | ﹤0.01% |
8,955
+7,541
| +533% | +$174K |
|
3694
Shinhan Financial Group
SHG
$33.2B
| $209K | ﹤0.01% |
7,500
| – | – |
|
3695
PUT
American Eagle Outfitters
AEO
$2.92B
| $209K | ﹤0.01% |
+15,000
| New | +$192K |
|
|
LX
3696
LexinFintech Holdings
LX
$242M
| $209K | ﹤0.01% |
110,000
| – | – |
|
3697
Hims & Hers Health
HIMS
$7.03B
| $209K | ﹤0.01% |
32,588
+27,442
| +533% | +$156K |
|
3698
Shore Bancshares
SHBI
$822M
| $209K | ﹤0.01% |
11,983
+4,683
| +64% | +$87.7K |
|
3699
Kodiak Sciences
KOD
$2.59B
| $208K | ﹤0.01% |
29,080
+6,895
| +31% | +$49.5K |
|
|
BQ
3700
Boqii Holding Ltd
BQ
$5.79M
| $207K | ﹤0.01% |
5,141
| – | – |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.